Natural products and adverse drug interactions

CMAJ. Canadian Medical Association Journal

Volumn 170, Issue 10, 2004, Pages 1531-1532

  Bailey, David G ^a   Dresser, George K ^b  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; CYTOCHROME P450; CYTOCHROME P450 3A4; DESOGESTREL; DIGOXIN; ETHINYLESTRADIOL; THEOPHYLLINE; WARFARIN;

DRUG METABOLISM; DRUG SAFETY; FOOD DRUG INTERACTION; GRAPEFRUIT JUICE; HEALTH FOOD; HUMAN; HYPERICUM PERFORATUM; PUBLIC HEALTH; SHORT SURVEY;

EID: 2542460298     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.1031558     Document Type: Short Survey

References (6)

1. Dresser GK, Spence JD, Bailey DG. Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition [review]. Clin Pharmacokinet 2000;38:41-57.
2. Bailey DG, Spence JD, Munoz C, Arnold JMO. Interaction of citrus juices with felodipine and nifedipine. Lancet 1991;337:268-9.
3. Maskalyk J. Grapefruit juice: potential drug interactions. CMAJ 2002; 167:279-80.
4. Lin JH, Yamazaki M. Role of P-glycoprotein in pharmacokinetics: clinical implications [review]. Clin Pharmacokinet 2003;42:59-98.
5. Ruschitzka F, Meier PJ, Turina M, Luscher TT, Noll G. Acute heart transplant rejection due to Saint John's wort. Lancet 2000;355:548-9.
6. Piscitelli SC, Burstein AH, Chaitt D, Alfaro RM, Falloon J. Indinavir concentrations and St John's wort [published erratum appears in Lancet 2001;357:1210]. Lancet 2000;355:547-8.